R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 44.25 PLN 2.08% Market Closed
Market Cap: 1B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

EV/EBIT
Enterprise Value to EBIT

-8.2
Current
-10.7
Median
23.2
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-8.2
=
Enterprise Value
855.9m PLN
/
EBIT
-104.9m PLN
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-17.1
2-Years Forward
EV/EBIT
-40.7
3-Years Forward
EV/EBIT
12.5

See Also

Discover More